Safety concerns growing over adjuvanted vaccines

Published: 2009-12-04 06:57:00

Updated: 2009-12-04 06:57:00

As concern over the safety of flu vaccines increases, a lawmaker feel a local drug company is putting profit above public safety, according to a lawmaker.

Currently, Korean drug-maker Green Cross Corp. has produced adjuvanted vaccines by an immunologic adjuvant from a Swiss pharmaceutical firm...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK